Cumberland Pharmaceuticals (CPIX) Equity Income (2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Equity Income came in at -$146080.0 in Q1 2026.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Equity Income (2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Equity Income across 1 years of filings, most recently posting -$146080.0 for Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | - |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | - |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | -10.46 Mn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | - |
| 10 | Cumberland Pharmaceuticals | 96.11 Mn | 92.24 Mn | - | - |